Nucleic Acid News and Research

RSS

New challenges for diagnosis of bacterial STIs

This year cases of sexually transmitted infections (STIs) have risen by 2% in the UK, in spite of a small drop in the incidence of syphilis and gonorrhoea, according to scientists speaking today (Wednesday 28 November 2007) at the Federation of Infection Societies Conference 2007 at the University of Cardiff, UK, which runs from 28-30 November 2007.

27 Nov 2007

New human rhinovirus associated with pediatric respiratory tract infection in Germany

Using a rapid, sensitive, and inexpensive diagnostic tool called MassTag PCR, scientists at Columbia University Mailman School of Public Health's Center for Infection and Immunity implicated a new human rhinovirus as the cause of severe pediatric respiratory tract infections in Europe.

21 Nov 2007

ClC-1 helps mice get a move on

In addition to the progressive muscle weakness and degeneration common to all forms of muscular dystrophy, patients with the most common form of muscular dystrophy affecting adults, myotonic dystrophy type 1 (DM1), also experience an inability to voluntarily relax the muscles (a problem known as myotonia).

16 Nov 2007

The key to unlocking the secret of highly specific DNAzyme catalysis

Using an extremely sensitive measurement technique, researchers at the University of Illinois have found clear evidence that a lead-specific DNAzyme uses the "lock and key" reaction mechanism.

13 Nov 2007

Genetic lab test for Warfarin sensitivity approved by FDA

The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.

18 Sep 2007

DNA and nanotechnology

DNA is one of the most popular building blocks of nanotechnology and is commonly used to construct ordered nanoscale structures with controlled architectures.

5 Sep 2007

FDA approves cobas TaqScreen WNV test for West Nile virus

The U.S. Food and Drug Administration has announced approval of a second test for the detection of West Nile virus (WNV) in blood and organs.

29 Aug 2007

FDA approves new Roche direct detection of West Nile Virus in donated human blood

Roche Diagnostics announced that the US Food & Drug Administration (FDA) has approved its biologics license application for the company's test for direct detection of West Nile Virus in donated human blood and plasma.

From Roche Sequencing and Life Science 29 Aug 2007

Biological markers of narcolepsy

The first report to identify the biological markers of narcolepsy using gene expression in white blood cells finds that the MX2 gene, which is relevant to the immune system, is significantly less expressed in narcoleptics compared with normal subjects.

2 Aug 2007

Xenomics issued European patent for Transrenal Nucleic Acid Technology for Prenatal Diagnostics

Xenomics, Inc. has announced the issuance of its first European patent "Methods for detection of nucleic acid sequences in urine", EP 1634966 A2 that covers use of its proprietary transrenal nucleic acid technology in the area of prenatal diagnostics and genetic testing.

1 Aug 2007

Luminex and Exiqon sign distribution agreement for microRNA products

Luminex Corporation and Exiqon A/S have announced the execution of a distribution agreement for the FlexmiR line of products co-developed by the companies in 2006.

From Luminex 11 Jul 2007

Breakthrough in understanding of noroviruses

A breakthrough announced this week by scientists at the University of Southampton's School of Medicine will lead to greater understanding of noroviruses, the most common cause of non-bacterial gastroenteritis around the world.

27 Jun 2007

Real-time, direct MRI monitoring of vector distribution within the brain

A team of scientists, led by Dr. Krystof Bankiewicz, University of California-San Francisco, presented this significant advance, which allows, for the first time, to adjust parameters of vector infusion while delivering gene therapy, giving surgeon full control over gene transfer technology.

3 Jun 2007

Novel technologies show promise for future of gene transfer

Several new technologies that could significantly impact the future of gene transfer applications were presented at a conference at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.

3 Jun 2007

New platform for regulating the expression of therapeutic genes

A new platform for regulating the expression of therapeutic genes, which will have major implications for gene and cell therapy, was presented at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.

3 Jun 2007

Nanoparticle delivery of insulin gene to fight juvenile diabetes developed

A safer method to deliver the insulin gene to diabetes patients using nanoparticles, was presented at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.

3 Jun 2007

Opt- out HIV testing in the Emergency Department

Using the new and highly publicized CDC guidelines for HIV screening, a university-based Emergency Department implemented opt-out screening in Washington, DC, where HIV infection rates are known to be high.

17 May 2007

3M and Gen-Probe collaborate to combat healthcare-associated infections

3M and Gen-Probe have announced that the companies have formed an exclusive worldwide collaboration to develop and commercialize rapid, easy-to-use nucleic acid tests to detect certain dangerous healthcare-associated infections (HCAIs) such as methicillin-resistant Staphylococcus aureus (MRSA).

1 May 2007

Luminex Corporation licenses cystic fibrosis gene patent from John Hopkins

Luminex Corporation has announced that it has acquired a non-exclusive license from The Johns Hopkins University for the rights to use the university's patented cystic fibrosis genetic markers in the company's molecular diagnostic products sold in the United States.

From Luminex 25 Apr 2007